LIAISON Testosterone xt— 510(k) K201908

Substantially Equivalent

DiaSorin, Inc.

FDA 510(k) clearance K201908 for LIAISON Testosterone xt, Substantially Equivalent on 2020-10-15. Applicant: DiaSorin, Inc..

Clearance details

Applicant: DiaSorin, Inc.
Product code: Code CDZ
Advisory panel: Clinical Chemistry
Date received: 2020-07-09
Decision date: 2020-10-15
Decision: Substantially Equivalent
Clearance type: Special
Location: Stillwater, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.